Fresenius Aktie
Kursziele der Fresenius-Aktie in EUR
Diese Analysten bewerten die Fresenius-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| DZ BANK | - | - | 10.08.2026 | |
| Jefferies & Company Inc. | 55,00 EUR | +16,16% | 07.08.2026 | |
| Deutsche Bank AG | 56,00 EUR | +18,27% | 06.08.2026 | |
| Barclays Capital | 57,50 EUR | +21,44% | 06.08.2026 | |
| JP Morgan Chase & Co. | 55,20 EUR | +16,58% | 06.08.2026 | |
| UBS AG | 54,00 EUR | +14,04% | 03.06.2026 | |
| Goldman Sachs Group Inc. | 48,00 EUR | +1,37% | 23.04.2026 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Baxter International Inc. | 0 | 0 | 0 | - | - |
| Becton, Dickinson & Co. (BD) | 0 | 0 | 0 | - | - |
| Boston Scientific Corp. | 0 | 0 | 0 | - | - |
| Carl Zeiss Meditec AG | 0 | 8 | 1 | 26,53 EUR | -14,20% |
| DaVita Inc Registered Shs | 0 | 0 | 0 | - | - |
| Drägerwerk AG & Co. KGaA Vz. | 0 | 2 | 0 | 90,00 EUR | -19,35% |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 40,81 EUR | -3,61% |
| Fresenius SE & Co. KGaA (St.) | 6 | 1 | 0 | 54,28 EUR | +14,64% |
| General Electric Co. | 0 | 0 | 0 | - | - |
| Hospira Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Medtronic PLC | 0 | 0 | 0 | - | - |
| Philips N.V. | 3 | 6 | 0 | 25,80 EUR | +9,09% |
| RHÖN-KLINIKUM AG | 0 | 0 | 0 | - | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Siemens AG | 6 | 2 | 1 | 290,88 EUR | +4,52% |
| Smith & Nephew plc | 0 | 0 | 0 | - | - |
| St. Jude Medical Inc. | 0 | 0 | 0 | - | - |
| Synthes Inc. | 0 | 0 | 0 | - | - |
| Zimmer Biomet | 0 | 0 | 0 | - | - |




